PLATO: Difference between revisions

Revision as of 16:51, 22 April 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

PLATO refers to the PLATelet inhibition and patient Outcomes trial.

Revision as of 16:45, 22 April 2014 (view source) Rim Halaby (talk \| contribs) No edit summary ← Older edit		Revision as of 16:51, 22 April 2014 (view source) Rim Halaby (talk \| contribs) No edit summary Newer edit →
Line 7:		Line 7:

	[[PLATO bleeding criteria\|Click here for PLATO bleeding criteria]]		[[PLATO bleeding criteria\|Click here for PLATO bleeding criteria]]

			[[Category:Clinical trials]]